A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) A61P 1/16 (2006.01) A61P 43/00 (2006.01) C12N 15/19 (2006.01)
Patent
CA 2425765
Preventives and/or remedies for liver diseases containing as the active ingredient monocyte chemoattractant protein-1 (MCP-1) function inhibitors. Administration of the MCP-1 function inhibitors exerts effects of preventing and/or treating liver diseases.
Cette invention concerne des médicaments préventifs ou curatifs pour maladies du foie, qui renferme des inhibiteurs de la fonction MCP-1 de la protéine-1 à facteur chimiotactique des monocytes comme principe actif. L'administration des inhibiteurs de la fonction MCP-1 à des effets préventifs et/ou curatifs pour les affections du foie.
Egashira Kensuke
Koyanagi Masamichi
Nakamuta Makoto
Nishida Ken-Ichi
Takeshita Akira
Daiichi Pharmaceutical Co. Ltd.
Egashira Kensuke
Gowling Lafleur Henderson Llp
LandOfFree
Novel drugs for liver diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel drugs for liver diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel drugs for liver diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2026318